Photo: Canada Beef Inc.

U.S. livestock: CME livestock futures rise on supply concerns

Chicago | Reuters – Chicago Mercantile Exchange livestock futures climbed on Wednesday, as cash cattle prices firmed on concerns around meat supplies to meet anticipated demand going into next year, traders said. Cattle futures ended higher, as beef carcass cutout prices continued to firm and cash cattle traded higher, traders said. Cash cattle traded at



Photo: iStock/Getty Images

U.S. grains: Soybean, corn slides on profit-taking amid South American weather woes

Chicago | Reuters – Chicago soybean futures fell on profit-taking on Tuesday, as uncertainty over weather forecasts in South America continued to spark questions over global supplies, traders said. Wheat prices fell sharply, extending losses from the previous session, as investors began to jockey their positions ahead of the year-end. And corn futures slipped, as

Photo: File

U.S. livestock: Cattle futures rise on expectations of beef demand; hogs ease

Chicago | Reuters – Chicago Mercantile Exchange cattle futures finished higher on Tuesday, as slaughter rates increased and carcass cutout values continued to firm, traders said. There is an expectation of beef prices continuing to firm and demand be strong going into the first quarter of 2022, said Doug Houghton, analyst with Brock Capital Management.


CME February 2022 lean hogs (candlesticks) with 20-, 50- and 100-day moving averages (pink, brown and dark red lines). (Barchart)

U.S. livestock: CME hog futures touch four-week high

Chicago cattle futures ease

Chicago | Reuters — U.S. hog futures rose for the fourth straight trading session on Monday, as the market continued to see support from a government report last week that showed smaller-than-expected national inventory numbers, traders said. Most-active February hog futures settled the day up 0.425 cent at 83.65 cents/lb. (all figures US$). Earlier in

CBOT March 2022 soybeans (candlesticks) with 20-, 50- and 100-day moving averages (yellow, green and black lines). (Barchart)

U.S. grains: Soybeans, corn extend rally

Dry South American weather stokes worries on crops; wheat prices move on technical trading

Chicago | Reuters — Chicago soybeans and corn extended gains on Monday to hit multi-month highs as dry and hot weather in South America stoked supply worries. Wheat rose early in the session, bolstered by hopes for greater export demand, but ended the day down on technical trading. Dealers said many market participants were still


CBOT March 2022 wheat (candlesticks) with Bollinger bands (20,2). (Barchart)

U.S. grains: Wheat slide continues in volatile week

Soybeans rise, corn up on support from crude oil prices

Chicago | Reuters — Chicago wheat futures slid once again on Friday, after a volatile week in which prices plunged on investor fears about the economic impact of the Omicron variant of COVID-19, traders said. Wheat prices had steadied early in the day’s session but then started falling again on news that U.S. employment growth



CBOT January 2022 soybeans (candlesticks) with 20- and 50-day moving averages (yellow and dark green lines). (Barchart)

U.S. grains: Grain futures regain ground as COVID jitters ease

Corn, soy firm after also hitting near three-week lows with wheat

Chicago | Reuters — Chicago wheat futures turned higher Wednesday, recouping some of their steep losses from the previous session, as investor concerns that the Omicron coronavirus variant would derail the global economy began to ease. Corn and soybeans also regained ground on end-user buying, traders said, following hopes of export buyers looking for deals

CBOT March 2022 wheat (candlesticks) with Bollinger bands (20,2). (Barchart)

U.S. grains: Wheat extends slide as Omicron worries mount

Corn, soybeans also slip on virus fears

Chicago | Reuters — Chicago wheat prices fell to a nearly three-week low on Tuesday, as concerns that the spread of the Omicron coronavirus variant could slow the global economy drove investors to reduce risk exposure. The entire grains complex felt pressure early in the session, after Moderna’s CEO cautioned that COVID-19 shots were unlikely